
A solid phase extraction-liquid chromatographic–tandem mass spectrometry method for determination of concentrations of GDC-0941, a small molecule class I phosphatidylinositide 3-kinase inhibitor, to support clinical development
Keywords: GDC-0941; Class I phosphatidylinositide 3-kinase (PI3K); 96-Well SPE; Human plasma; LC–MS/MS